Clubhouse Meets Masterclass! Wisdom App Launches World’s Largest Mentorship Platform via Social Audio
14.10.2021 19:00:00 EEST | Business Wire | Press release
Wisdom – the social audio app built to democratise mentorship – is now live in the UK, the US, Australia, and Canada. Founded by Dayo Akinrinade, the Wisdom app is an inclusive space where diverse people come together to have conversations that matter.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211014005070/en/
Photo of Dayo Akinrinade, founder and CEO of social audio app Wisdom (Photo: Business Wire)
On a mission to become the next big social audio community, Wisdom taps into the intimacy and authenticity provided by the emerging medium. Drop-in social audio is transforming social networking because it takes interactions and conversations back to their roots. As the oldest medium, and one that is the most “human” of all societal interactions, audio is the antithesis of the heavily filtered nature of today’s visual-led apps and one which helps amplify voices of all groups and communities.
Wisdom is the latest app to launch in the white hot social audio market. Unlike other social audio applications, like Clubhouse, Wisdom is designed from the ground up to promote conversations that matter: conversations of substance on a topic of importance. Members can chat live with experts in dozens of topics from parenting, fitness, and dating to startups, mental health, and beauty. They can listen live or playback the recordings in their own time.
In Wisdom, when a mentor starts a talk, listeners can queue up to ask questions. A timer keeps the conversation moving so no one guest can monopolise the conversation; making sure all voices are heard. Inspired by Tiktok, Wisdom leverages an algorithm-first design that quickly learns what members like to listen to. Talk recommendations are made by a deep-learning neural network.
Dayo Akinrinade, founder and CEO of Wisdom, said: “I founded Wisdom to democratise access to mentorship. During my time at OneTech, London's largest diversity in startups programme, I noticed that diverse individuals from underrepresented groups lack access to mentoring. I also personally experienced how impossible it is to use platforms like LinkedIn for mentoring. The inboxes of experts are inundated with “pick your brain” requests which end up ignored unless the request is via a warm introduction, which is itself a crystallisation of systemic inequality.”
A global platform for mentorship
Connecting with others in a meaningful way has been proven to make people happier, with deep conversations with strangers more enjoyable than small talk. Wisdom will cultivate this, with thousands of people already signed up as mentors, making it the largest platform for mentorship in the world. These experts will be able to use Wisdom to share their knowledge, interact directly with their audience and give back while getting on the ground floor of the next big social audio community.
Though the platform will be free to members, as part of its mission to democratise mentorship, Wisdom will also empower its mentors through monetisation tools so they can grow their own businesses. Monetisation features will be added to Wisdom later this year.
Akinrinade added: “Consider that Masterclass has no more than hundreds of experts on its platform and does not allow deep interactions and is not free. With Wisdom, we are building something very different. Ultimately what we are building with Wisdom is a new social graph … the Mentor Graph. This is not a messy ‘talk graph’ of anyone on any topic but a social graph of the people who can help jumpstart a career, or change a life for the better. People today hunger for conversations that matter. We believe Wisdom is the platform where these conversations can live.”
The Wisdom app is available for download today for iPhone. Android is coming soon.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211014005070/en/
Contact information
Joyce Omope
joyce@burlington.cc
+44 (0) 7599 672542
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 11:15:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
